ASCVD 10-year Risk (PCE)
Estimate 10-year atherosclerotic cardiovascular disease risk using the 2013 ACC/AHA Pooled Cohort Equations.
Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Age
- 55 years
- Total cholesterol
- 213 mg/dL
- HDL cholesterol
- 50 mg/dL
- Systolic BP
- 120 mmHg
- Sex
- M
- Race
- White / Other
Result: ASCVD PCE ~5-7% 10-year risk (borderline to low risk; race/treated/smoke/dm modifiers shift the band).
The tool opens with these values already filled in. Replace them with your own.
What the result means
- <5%
- Low 10-year ASCVD risk.
- 5-7.4%
- Borderline 10-year ASCVD risk; risk-enhancing factors may favor therapy per source.
- 7.5-19.9%
- Intermediate 10-year ASCVD risk.
- >=20%
- High 10-year ASCVD risk.
What you enter
- Age (40-79)
- Total cholesterol
- HDL cholesterol
- Systolic BP
- Sex
- Race (white/other or African-American; PCE only)
- On treatment for hypertension
- Smoker
- Diabetes
What this is
Sophie Well takes age, sex, race, total and HDL cholesterol, systolic blood pressure (treated or untreated), diabetes, and smoking, and returns the 10-year ASCVD risk percentage along with the conventional risk band (low/borderline/intermediate/high). PCE retains race-stratified equations. Source: Goff DC Jr et al, Circulation 2014.
When to use it
Use ASCVD for primary-prevention risk stratification in adults 40-79 without existing cardiovascular disease. The result anchors statin and aspirin conversations under current ACC/AHA guidelines. PCE is known to over-estimate in some contemporary cohorts; the newer PREVENT equations (separate tool) drop race and add kidney function and SDoH and may be preferred when validated.
How this is calculated
Goff DC Jr, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: Pooled Cohort Equations. Circulation. 2014;129(25 Suppl 2):S49-73. PCE retains race-stratified equations (white vs African-American). Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.
More in Cardiology.